MEGHAN BALDWIN: Open Payments
NPI 1598172009 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 21 payments from 10 companies in 2025. Trend: 2023 $701 · 2024 $650 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $294 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $184 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| LivaNova USA, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Alkermes, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
Products named: SUBLOCADE, CAPLYTA, Auvelity, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, COBENFY, LYBALVI, INGREZZA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
